Latest News

Press Release
October 8, 2020
Sweet Ventures invests in BOYDSense to bring non-invasive glucose monitoring using breath analysis to people with diabetes
[…]
Read More
Press Release
October 28, 2019
BOYDSense diabetes device places among top innovations at 2019 RESI Innovation Challenge
San Bruno, Calif. – October 29, 2019 – Medical technology company BOYDSense, Inc. has returned from the RESI (Redefining Early Stage Investments) conference in Boston with a second-place finish in the RESI Innovation Challenge and myriad accolades […]
Read More
News
September 12, 2019
From 38 Finalists. RESI Boston’s Audience Selects Innovation Challenge Champions
Boston, Mass. - September 12, 2019 - The RESI Innovation Challenge showcased 38 emerging startups in the biotech, medtech, diagnostics and digital health fields. All the competitors brought novel, exciting discoveries to the technology showcase […]
Read More

Videos

BOYDSense leaders speak about founding BOYDSense, its mission, the inspiration for the company name, the product, the technology, and more.

Our Inspiration

Bruno Thuillier, Founder & CEO

Our Vision

Bruno Thuillier, Founder & CEO

Our Expertise

Bruno Thuillier, Founder & CEO

Lassie Prototype Demo

Joel Rabasco, Product Management

I. Paired testing and the benefits of non-invasive glucose monitoring

William Polonsky, PhD, Advisor

II. An example of paired testing: the Beer Experiment

William Polonsky, PhD, Advisor

III. Why I'm excited to advise BOYDSense

William Polonsky, PhD, Advisor

Ambrosia Investments and Jolt Capital are majority shareholders in BOYDSense’s parent company Alpha-MOS.

Awards

Here are a few of the honors we’ve received

Media

For all media inquiries please email us at:

info@boydsense.com